Small-cell lung cancer (SCLC) causes cells in lung tissue to mutate and grow uncontrollably. When these cells look different than healthy cells under a microscope, doctors call this poorly ...
Tumor grading via least differentiation analysis was found to be a way to measure the risk of lymph node metastasis (LNM) in patients with submucosal invasive colorectal cancer (CRC). Tumor grading ...
A randomized phase II trial of interleukin-2/interferon-α plus bevacizumab versus interleukin-2/interferon-α in metastatic renal cell carcinoma (mRCC): Results from ...
A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC). Combined treatment with TLR7/8 agonists and carbon ...